Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial - The KADS study.

Saved in:
Bibliographic Details
Title: Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial - The KADS study.
Authors: Chatterton ML; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia; Institute for Health Transformation, Deakin University, Geelong, Australia. Electronic address: m.chatterton@monash.edu., Perez JK; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Thai T; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Faller J; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Loo CK; Black Dog Institute; University of New South Wales, Randwick, New South Wales, Australia; The George Institute for Global Health, Newtown, New South Wales, University of New South Wales, Australia., Glozier N; Central Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia; Australian Research Council Centre of Excellence for Children and Families over the Life Course, University of Sydney, Sydney, New South Wales, Australia., Barton D; Australian Centre for Heart Health, Royal Melbourne Hospital, North Melbourne, Victoria, Australia; NeuroCentrix, South Carlton, Victoria, Australia., Baune BT; Department of Psychiatry, University of Münster, Münster, Germany; Department of Psychiatry, Melbourne Medical School, University of Melbourne, Melbourne, Victoria, Australia; Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia., Mills NT; Discipline of Psychiatry, Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia., Fitzgerald PB; Australian National University School of Medicine and Psychology, Canberra, Australian Capital Territory, Australia., Glue P; Dunedin School of Medicine, University of Otago, Dunedin, New Zealand., Sarma S; Mental Health and Specialist Services, Gold Coast Health, Southport, Queensland, Australia; Bond University, Robina, Queensland, Australia., Hadzi-Pavlovic D; Discipline of Psychiatry and Mental Health, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia., Dong V; Black Dog Institute; University of New South Wales, Randwick, New South Wales, Australia., Martin D; University of New South Wales, Randwick, New South Wales, Australia; The George Institute for Global Health, Newtown, New South Wales, University of New South Wales, Australia; Discipline of Psychiatry and Mental Health, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia., Mitchell PB; Discipline of Psychiatry and Mental Health, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia., Berk M; Deakin University, Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Barwon Health, Geelong, Australia., Carter G; College of Health, Medicine and Wellbeing, School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia., Hackett M; The George Institute for Global Health, Newtown, New South Wales, University of New South Wales, Australia., Hood S; Division of Psychiatry, University of Western Australia, Perth, Western Australia, Australia., Somogyi AA; Discipline of Pharmacology, School of Biomedicine, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia., Rodgers A; The George Institute for Global Health, Newtown, New South Wales, University of New South Wales, Australia., Mihalopoulos C; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia; Institute for Health Transformation, Deakin University, Geelong, Australia.
Source: Journal of affective disorders [J Affect Disord] 2025 Oct 15; Vol. 387, pp. 119502. Date of Electronic Publication: 2025 May 28.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7906073 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2517 (Electronic) Linking ISSN: 01650327 NLM ISO Abbreviation: J Affect Disord Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1573-2517
DOI:10.1016/j.jad.2025.119502